Blood, 1 April 2003, Vol. 101, No. 7, pp. 2460-2460
ERRATUM
Regarding the article by Wanless et al entitled "Lack of progressive
hepatic fibrosis during long-term therapy with deferiprone in subjects
with transfusion-dependent beta-thalassemia," which appeared in the
September 1, 2002, issue of Blood (Volume 100:1566-1569), please note the following additional statement by the authors:
R.G. (Renzo Galanello), A.P., R.G. (Rita Gamberini), and A.C. have
received support from Apotex for other research studies and have
received reimbursement for travel expenses related to meetings of
investigators and scientific meetings at which results were presented.
E.S. served on the Data and Safety Monitoring Committee for other
Apotex-sponsored trials and received reimbursement for travel expenses
related to meetings of this committee. The present study received no
support from Apotex, and none of the authors involved in the
interpretation of the liver biopsies or the analysis of the data
received previous support from Apotex.
Editor's note: This financial disclosure was provided at the
request of the journal and was not information originally
withheld.
